Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: July

Request Number: A-2023-001331

Request Summary: Advise whether the Mesalazine Abbreviated New Drug Submission (ANDS) has received either: a Screening Acceptance Letter; a Notice of Deficiency (NOD); a Notice of Non-Compliance (NON); a NOD-Withdrawal (NOD-W); or a NON-Withdrawal (NON-W).

Disposition: Disclosed in part

Number of pages: 27

Date modified: